Modular Medical sets 2027 virtual shareholder meeting
Modular Medical set an October 23, 2026 virtual annual meeting and a September 13, 2026 deadline for shareholder proposals and director nominations.
Rhea-AI Filing Summary
Modular Medical, Inc. (MODD) announced that its fiscal 2027 Annual Meeting of Shareholders will be held as a virtual meeting on October 23, 2026. Shareholders of record at the close of business on September 10, 2026 will be entitled to receive notice of and vote at the meeting.
Shareholder proposals and director nominations for the 2027 Annual Meeting must be received by the Company’s Secretary at its San Diego principal executive offices by 5:00 p.m. (Eastern time) on September 13, 2026, whether for inclusion in proxy materials under Rule 14a-8 or brought outside Rule 14a-8 under the Company’s bylaws. Shareholders intending to use the universal proxy rules for their own director nominees must also provide the Rule 14a-19 notice by this same deadline.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.08 — Shareholder Director Nominations
1 item
Item 5.08
Shareholder Director Nominations
Governance
Shareholder nominations for board of directors under proxy access rules. Rarely used -- the underlying SEC rule was vacated.
Key Figures
2027 Annual Meeting date: October 23, 2026
Record date: September 10, 2026
Proposal and nomination deadline: 5:00 p.m. Eastern, September 13, 2026
+1 more
4 metrics
2027 Annual Meeting date
October 23, 2026
Date set by the board of directors for the fiscal 2027 Annual Meeting of Shareholders
Record date
September 10, 2026
Shareholders of record on this date are entitled to notice of and to vote at the 2027 Annual Meeting
Proposal and nomination deadline
5:00 p.m. Eastern, September 13, 2026
Deadline for Rule 14a-8 proposals, other business under bylaws, and Rule 14a-19 universal proxy notices
Principal executive office phone
(858) 800-3500
Telephone number listed for Modular Medical’s principal executive offices
Key Terms
Rule 14a-8, universal proxy rules, Rule 14a-19, bylaws, +1 more
5 terms
Rule 14a-8 regulatory
"proposal considered for inclusion in the Company’s proxy materials for the 2027 Annual Meeting pursuant to Rule 14a-8"
Rule 14a-8 is a U.S. Securities and Exchange Commission regulation that lets eligible shareholders put proposals on a public company’s proxy ballot for an annual meeting, provided they meet basic ownership and filing requirements. It matters to investors because it creates a formal way to raise governance or strategic issues and force a company-wide vote—like getting an item onto the agenda of a neighborhood association meeting once you’ve lived there long enough—so shareholders can push for change or influence management decisions.
universal proxy rules regulatory
"In addition, to comply with the universal proxy rules, shareholders who intend"
Universal proxy rules require that when shareholders vote to elect directors in a contested election, the proxy card mailed to investors can include candidates nominated by both the company and dissident shareholders, letting investors mix and match their choices on a single ballot. This matters to investors because it makes their vote more flexible and easier to use, like replacing separate lists with one common ballot, which can influence who controls the board and the company’s future direction.
Rule 14a-19 regulatory
"information required by Rule 14a-19 under the Exchange Act by 5:00 p.m."
Rule 14a-19 is a U.S. Securities and Exchange Commission rule that governs how independent proxy advisory firms produce and distribute voting recommendations for shareholders. It requires these advisers to provide companies with notice of their recommendations and a chance to respond, and to disclose certain conflicts; think of it as a referee ensuring both sides see a game plan before fans cast votes. Investors care because proxy advisers influence voting outcomes and corporate governance, so the rule affects transparency, potential bias, and the reliability of guidance that many investors rely on when voting shares.
bylaws regulatory
"in accordance with the requirements contained in the Company’s bylaws, shareholders"
Corporate bylaws are a company's internal rulebook that explains how the business is run day to day — who makes decisions, how directors and officers are chosen, how shareholder meetings are conducted, and procedures for changes or conflicts. For investors, bylaws matter because they shape governance and control, influence how quickly and easily leadership or strategy can change, and can protect or limit shareholder rights much like house rules affect how a household operates.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What is the record date for voting at MODD’s 2027 Annual Meeting?
Shareholders of Modular Medical who are of record at the close of business on September 10, 2026 will be entitled to notice of and to vote at the 2027 Annual Meeting.
What are the universal proxy notice requirements for MODD’s 2027 Annual Meeting?
Shareholders intending to solicit proxies for director nominees other than Modular Medical’s nominees must provide notice with the information required by Rule 14a-19 by 5:00 p.m. (Eastern time) on September 13, 2026, the tenth calendar day after public announcement of the meeting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
